Advisory Board and Editors COVID-19
Pragyan Acharya
Dr. Pragyan Acharya is an Associate Professor in the Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. The major interests of her laboratory is in understand immune dysregulation in liver diseases and understanding the interaction of the immune system in tissue injury and infection. Towards this, she combines studies on clinical samples, in vitro cultures and animal models of liver disease. She is specifically studying non-alcoholic fatty liver disease (NAFLD) and acute-on-chronic liver failure (ACLF) using proteomics and cell biological approaches. Work carried out in her laboratory has led to the identification of the importance of the CD177+ neutrophil sub-population in ACLF and its association with patient outcomes.
Mohd Adnan
Prof. Dr. Mohd Adnan is a Principal Investigator and Head of Academic Committee at Department of Biology, College of Science, University of Ha'il, Saudi Arabia. He did his PhD from University of Central Lancashire, UK; Master’s and Bachelor’s degree from Bangalore University, India; Post Graduate Diploma in Bioinformatics from SJAIT, India. He has more than 14 years of research, teaching and administrative experience. In his professional capacity, he has received various travel, observership and research grants as a Principal Investigator from various prestigious organizations.
He has successfully published 250+ publications in internationally recognized peer reviewed reputed journals, several book chapters for internationally renowned publishers and presented many papers and posters in various conferences/workshops globally. He has published widely in the field of phytomedicine, biofilms, drug discovery, natural products, nutraceuticals and functional foods with specialization in plant-based antibiofilm and anticancer agents, microbial biosurfactants, biofilms in food industry and medical settings, probiotics and cancer biology, novel biomolecules for/as health and antimicrobial agents.
He has reviewed 400+ manuscripts for 70+ internationally recognized peer-reviewed JCR journals and grant reviewer for many prestigious universities and organisations. In addition, he is a member of SFAM, UK and ESCMID, Switzerland and an Elected Member of Royal Society of Biology, UK. He also currently holds different editorial positions (Associate, Academic, Guest and Review Editor) in various esteemed journals and has edited 500+ manuscripts.
Claudio Andaloro
Dr. Claudio Andaloro is MD at Department of Surgery, Otolaryngology Unit, Latisana-Palmanova Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy. His research interests focus on rhinology, laryngology, pediatric otolaryngology and sleep medicine.
José Alberto Benítez-Andrades
Jose Alberto Benítez-Andrades received the B.S. degree in Computer Engineering and PhD in Production Engineering and Computing from the University of León, Spain, in 2010 and 2017 respectively. He is Associate Professor at the University of León. His research is related to the application of artificial intelligence techniques, knowledge engineering and social network analysis applied mainly to problems related to the field of health. He has more than 40 publications indexed in JCR, 30 communications in international conferences, is associate editor of the journal BMC Medical Informatics and Decision Making, has organized several international conferences since 2018 and is an evaluator of international projects for the government of Spain and Peru.
Chengming Fan
Prf. Chengming Fan is a Surgeon in the Department of Cardiovascular Surgery at Central South University. HIs current basic research interests include treatment of ischemic heart disease with human induced pluripotent stem cells (hiPSC)-related strategy and with preclinical animal models.
B. Brett Finlay
The Peter Wall Distinguished Professor of the University of British Colombia. Recipient of several awards including the E.W.R. Steacie Prize, the CSM Fisher Scientific Award, an MRC Scientist, five Howard Hughes International Research Scholar Awards, a CIHR Distinguished Investigator, BC Biotech Innovation Award, the Michael Smith Health Research Prize, the IDSA Squibb award, the Jacob Biely Prize. Cofounder of Inimex Pharmaceuticals, Inc., and Director of the SARS Accelerated Vaccine Initiative
Maria Elena Flacco
Prof. Maria Elena Flacco is Associate Professor of Epidemiology, Medical Statistics and Public Health at the University of Ferrara, Italy. Her areas of research include epidemiology, public and occupational health, and biostatistics and methods.
Fanglin Guan
Prof. Fanglin Guan is Dean at Xi'an Jiaotong University. He is engaged in the integrated biological research of complex diseases, including tumor microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumor cell vaccines, especially for the exploration of the mechanism of determining the biomarkers of complex diseases.
Altijana Hromić-Jahjefendić
Dr. Altijana Hromić-Jahjefendić is an associate professor at the Genetics and Bioengineering Department at International University of Sarajevo, Bosnia and Herzegovina. She obtained her bachelor's degree in chemistry and master's degree in Biochemistry and Molecular Biomedicine at Graz University of Technology, Austria. After that she worked for Austrian Center of Industrial Biotechnology and continued to pursue her PhD degree in Biochemistry and Molecular Biomedicine with the focus on Structural biology. Since 2018. she works as professor at International University of Sarajevo at the Genetics and Bioengineering Department. She authored many scientific publications with international colleagues in the field of COVID-19 and cancer research.
Mohamed Lounis
Dr Mohamed Lounis is a Lecturer at the Department of Agroveterinary Sciences, University of Ziane Achour Djelfa, Algeria. He completed his PhD in veterinary epidemiology from the University of Blida in 2018.
His research broadly concentrates on human and animal epidemiology. More precisely, he began his research on animal colibacillosis including calf and avian colibacillosis with Escherichia coli genotyping and phenotyping and antibiotic resistance. Later, he conducted multiple studies related to the epidemiology of COVID-19 in Algeria and in Arabic countries. These works were mainly based on modeling the propagation of the disease and the attitudes toward COVID-19 and its vaccines.
Dr. Lounis is also working on a One health approach through different surveys about multiple animal and public health threats including drug use and antibiotic resistance, infectious diseases including HPV infections, AIDS, monkeypox, viral hepatitis (A-E) and other zoonotic diseases including bacterial (tuberculosis, brucellosis...), parasitic (echinococcosis, leishmaniasis…) and viral (rabies, arboviroses…) diseases. He is also working on the epidemiology of non transmissible diseases including cancer, diabetes, hypertension..
Carla N Mavian
My research aims at understanding the eco-evolutionary pathways that lead to emergence and dispersal of zoonotic and human pathogens, with emphasis on land use and climate change, within the One Health approach. I employ genomics, metagenomics and phylodynamics as tools to elucidate the evolutionary processes and population dynamics that shape viral genetic diversity both at the inter-host (epidemics) and in intra-host level (individual infections).
Felipe G Naveca
I am a microbiologist with experience in classical and molecular techniques applied to the study of human pathogens, mainly threatening RNA and DNA viruses. My research focuses on developing diagnostic tools, molecular epidemiology, and evolution, mostly on emergent and reemergent viruses. My team approaches include genomics and phylogenetic studies to characterize known and unknown viruses; field studies on arboviral emergence in a rural area in the Brazilian Amazon; immunogenetics studies related to susceptibility or resistance against microbial infections; studies on biomarkers of acute viral illness; in vitro & in vivo virus-host interactions and evolution; and SARS-CoV-2 and other respiratory viruses molecular epidemiology. Senior investigator of Fiocruz Amazonas and Deputy Director of Research and Innovation. Member of the Brazilian Society for virology since 1997. Member of the Brazilian network of specialists in Zika and correlated diseases.